| FIDCX | RMBKX | FIDCX / RMBKX | |
| Total Expense Ratio | 1.99 | 1.33 | 150% |
| Annual Report Gross Expense Ratio | 2.00 | 1.33 | 150% |
| Fund Existence | 28 years | 27 years | - |
| Gain YTD | 6.790 | 19.593 | 35% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 279M | 246M | 113% |
| Annual Yield % from dividends | 0.25 | 0.76 | 33% |
| Returns for 1 year | -31.65 | 22.36 | -141% |
| Returns for 3 years | -7.33 | 78.13 | -9% |
| Returns for 5 years | -42.59 | 25.28 | -168% |
| Returns for 10 years | -24.44 | 97.77 | -25% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BULZ | 39.42 | 0.70 | +1.81% |
| MicroSectors™ Slct FANG Inn 3X Lvgd ETNs | |||
| KIQQ | 24.83 | 0.21 | +0.85% |
| KraneSharesInspereXNasdaqDynBfrdHInIdETF | |||
| NEMD | 51.92 | -0.02 | -0.05% |
| Neuberger Em Mkts Debt Hard Ccy ETF | |||
| NUSA | 22.81 | -0.02 | -0.07% |
| Nuveen ESG 1-5 Year US Aggt Bd ETF | |||
| LABU | 261.30 | -4.70 | -1.77% |
| Direxion Daily S&P Biotech Bull 3X ETF | |||